Nytt fiskepatogen

A fish virus, which, when injected intraperitoneally or intramuscularly in doses of 0.1-.2 ml/fish of an infected GF-1 cell homogenate prepared from first passage of the virus, has the ability to introduce the symptoms and disease of Cardiomyopathy Syndrome (CMS), wherein said virus is the strain de...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Frøystad-Saugen, Marianne, Alexandersen, Svein, Rode, Marit, Solbakk, Inge Tom, Eliassen, Trygve Meum
Format:	Patent
Sprache:	nor
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY FODDER FOODS OR FOODSTUFFS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS THEIR TREATMENT, NOT COVERED BY OTHER CLASSES VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	A fish virus, which, when injected intraperitoneally or intramuscularly in doses of 0.1-.2 ml/fish of an infected GF-1 cell homogenate prepared from first passage of the virus, has the ability to introduce the symptoms and disease of Cardiomyopathy Syndrome (CMS), wherein said virus is the strain deposited under the Budapest Treaty with the European Collection of Cell Culture (ECACC) under accession number 07032902 or a strain with related genotypic and/or phenotypic characteristics, and/or said virus reacts with immune serum from rabbit raised against the strain deposited under ECACC accession number 07032902. A vaccine comprising the aforementioned virus or a component or part thereof is also claimed. Methods of isolating the virus of the invention, and methods of treatment of CMS using vaccines of the invention are also disclosed.